Search
Now showing items 1-9 of 9
Safety Issues, DNA & MVA HIV Vaccine Trials at KAVI Oral presentation
(University of Nairobi, 2003-01)
The Use of Viral Peptides as a Quality Control for ELISPOT Assays in HIV-1 Vaccine Trials in Kenya
(University of Nairobi,, 2004)
Abstract no. A10065"
CD4+ and CD8+lymphocyte distribution among healthy Kenyans
(University of Nairobi, 2004)
Effectiveness of syndromic approach to STI management in a high risk cohort, Nairobi, Kenya
(University of Nairobi, 2009)
Enhanced volunteer recruitment in HIV vaccine trials in Kenya
(University of Nairobi, 2004)